Kewaunee Scientific (KEQU) Competitors $57.60 -0.85 (-1.45%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$57.52 -0.09 (-0.15%) As of 07/15/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KEQU vs. EYPT, ALNT, LAB, CTKB, AEHR, QSI, QTRX, SENS, MASS, and FEIMShould you be buying Kewaunee Scientific stock or one of its competitors? The main competitors of Kewaunee Scientific include Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), Senseonics (SENS), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry. Kewaunee Scientific vs. Its Competitors Eyepoint Pharmaceuticals Allient Standard BioTools Cytek Biosciences Aehr Test Systems Quantum-Si Quanterix Senseonics 908 Devices Frequency Electronics Kewaunee Scientific (NASDAQ:KEQU) and Eyepoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends and analyst recommendations. Which has more risk & volatility, KEQU or EYPT? Kewaunee Scientific has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Eyepoint Pharmaceuticals has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Do insiders & institutionals believe in KEQU or EYPT? 32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 99.4% of Eyepoint Pharmaceuticals shares are owned by institutional investors. 13.3% of Kewaunee Scientific shares are owned by insiders. Comparatively, 4.5% of Eyepoint Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, KEQU or EYPT? Kewaunee Scientific has higher revenue and earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKewaunee Scientific$240.47M0.71$11.40M$3.8315.04Eyepoint Pharmaceuticals$43.27M15.65-$130.87M-$2.41-4.08 Does the media refer more to KEQU or EYPT? In the previous week, Eyepoint Pharmaceuticals had 5 more articles in the media than Kewaunee Scientific. MarketBeat recorded 6 mentions for Eyepoint Pharmaceuticals and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.89 beat Eyepoint Pharmaceuticals' score of 0.51 indicating that Kewaunee Scientific is being referred to more favorably in the media. Company Overall Sentiment Kewaunee Scientific Very Positive Eyepoint Pharmaceuticals Positive Do analysts prefer KEQU or EYPT? Eyepoint Pharmaceuticals has a consensus price target of $25.67, indicating a potential upside of 160.84%. Given Eyepoint Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Eyepoint Pharmaceuticals is more favorable than Kewaunee Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Eyepoint Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is KEQU or EYPT more profitable? Kewaunee Scientific has a net margin of 4.74% compared to Eyepoint Pharmaceuticals' net margin of -261.91%. Kewaunee Scientific's return on equity of 26.02% beat Eyepoint Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Kewaunee Scientific4.74% 26.02% 9.87% Eyepoint Pharmaceuticals -261.91%-54.27%-41.75% SummaryKewaunee Scientific beats Eyepoint Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get Kewaunee Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KEQU vs. The Competition Export to ExcelMetricKewaunee ScientificINSTRU IndustryComputer SectorNASDAQ ExchangeMarket Cap$172.25M$1.13B$27.98B$9.29BDividend YieldN/A0.46%3.14%4.03%P/E Ratio15.0431.9133.0119.58Price / Sales0.711.371,765.7694.56Price / Cash7.9627.9937.6457.93Price / Book2.483.137.465.54Net Income$11.40M$17.67M$779.73M$257.73M7 Day Performance-3.94%-1.03%-0.66%-0.08%1 Month Performance52.99%8.34%4.90%8.09%1 Year Performance10.83%-20.68%52,715.15%13.02% Kewaunee Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KEQUKewaunee Scientific0.9701 of 5 stars$57.60-1.5%N/A+10.8%$172.25M$240.47M15.041,239Positive NewsEYPTEyepoint Pharmaceuticals1.593 of 5 stars$9.49-2.4%$25.67+170.5%-6.6%$668.85M$43.27M-3.94120ALNTAllient2.2358 of 5 stars$37.89-2.2%$31.00-18.2%+44.4%$656.17M$516.06M64.222,525LABStandard BioTools3.7992 of 5 stars$1.28-5.2%$2.50+95.3%-42.2%$512.76M$174.43M-3.66620Positive NewsCTKBCytek Biosciences3.0432 of 5 stars$3.40-9.6%$5.60+64.7%-48.7%$476.24M$200.45M-37.77500News CoverageAEHRAehr Test Systems3.4308 of 5 stars$14.82-5.0%$25.00+68.7%-14.5%$464.43M$66.22M19.0090QSIQuantum-Si1.8186 of 5 stars$1.83-14.5%$3.48+89.9%+59.3%$392.69M$3.06M-2.69150Gap UpQTRXQuanterix2.5631 of 5 stars$6.30-9.7%$15.60+147.6%-63.6%$348.68M$137.42M-4.85460SENSSenseonics1.9974 of 5 stars$0.49-2.6%$1.55+216.8%+11.3%$320.11M$23.68M-3.7690News CoverageAnalyst ForecastAnalyst RevisionMASS908 Devices1.1126 of 5 stars$6.41-3.6%$5.33-16.8%+17.5%$238.48M$59.63M-11.8760Positive NewsFEIMFrequency Electronics1.587 of 5 stars$20.82-2.8%N/A+105.4%$207.17M$55.27M8.64200Earnings ReportUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies EYPT Alternatives ALNT Alternatives LAB Alternatives CTKB Alternatives AEHR Alternatives QSI Alternatives QTRX Alternatives SENS Alternatives MASS Alternatives FEIM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KEQU) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kewaunee Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Kewaunee Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KEQU Stock Alerts